Browse by author
Lookup NU author(s): Daniel Collerton, Professor John-Paul TaylorORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Treatment of visual hallucinations in neurodegenerative disorders is not well advanced. The complexity of underlying mechanisms presents a number of potential avenues for developing treatments, but also suggests that any single one may be of limited efficacy. Reducing medication, with the careful introduction of antidementia medication if needed, is the mainstay of current management. Antipsychotic medication leads to excessive morbidity and mortality and should only be used in cases of high distress that do not otherwise respond. Education, reduction of risk factors and psychological treatments have limited evidence of efficacy, but are unlikely to cause harm
Author(s): Collerton D, Taylor J-P
Publication type: Review
Publication status: Published
Journal: Future Neurology
Year: 2013
Volume: 8
Issue: 4
Pages: 433-444
Print publication date: 01/07/2013
ISSN (print): 1479-6708
ISSN (electronic): 1748-6971
URL: http://dx.doi.org/10.2217/fnl.13.19
DOI: 10.2217/fnl.13.19
PubMed id: 3882162